Advertisement

Clinical Perspective: Electrophysiology in the Young and Patients with Congenital Heart Disease

  • James C. Perry
Chapter

Abstract

Young patients and those with congenital heart disease (CHD) manifest all forms of cardiac arrhythmia, but the age of presentation varies considerably, and the indications for intervention differ from adults. Much remains to be discovered about the underlying mechanisms of pediatric and congenital heart arrhythmia and even more about the true indications and benefits of pacemaker, defibrillator, and resynchronization device management strategies. The purpose of this chapter is to review the age-dependent presentation of cardiac arrhythmias, their relation to structural congenital cardiac defects, and the growing implication of the needs of the adult population with CHD for improved heart failure and primary prevention guidelines.

Keywords

Congenital Heart Disease Right Ventricle Cardiac Resynchronization Therapy Right Bundle Branch Block Implantable Cardiac Defibrillator 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations

AAD

antiarrhythmic drug

AV

atrioventricular

ccTGA

congenitally corrected transposition of the great arteries

CHD

congenital heart disease

CRT

cardiac resynchronization therapy

d-TGA

d-transposition of the great arteries

EP

electrophysiologic

ICD

implantable cardioverter-defibrillator

RBBB

right bundle branch block

SNP

single nucleotide polymorphism

SVT

supraventricular tachycardia

TOF

tetralogy of Fallot

VSD

ventricular septal defect

VT

ventricular tachycardia

WPW

Wolff–Parkinson–White syndrome

References

  1. 1.
    Khairy P. EP challenges in adult congenital heart disease. Heart Rhythm 2008; 5:1464–72.PubMedCrossRefGoogle Scholar
  2. 2.
    Ko JK, Deal BJ, Strasburger JF, et al. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol 1992; 69:1028–32.PubMedCrossRefGoogle Scholar
  3. 3.
    Perry JC. Supraventricular tachycardia. In: Garson A Jr, Bricker JT, Fisher DJ, Neish SN, editors. The science and practice of pediatric cardiology, 2nd edition. Philadelphia: Lea & Febiger, 1997.Google Scholar
  4. 4.
    Perry JC, Garson A Jr. Supraventricular tachycardia due to Wolff-Parkinson-White in children: early disappearance and late recurrence. J Am Coll Cardiol 1990; 16:1215–20.PubMedCrossRefGoogle Scholar
  5. 5.
    Weindling SN, Saul JP, Gamble WJ, et al. Duration of complete atrioventricular block after congenital heart disease surgery. Am J Cardiol 1998; 82:525–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Hokanson JS, Moller JH. Significance of early transient complete heart block as a predictor of sudden death after portative correction of tetralogy of Fallot. Am J Cardiol 2001; 87:1271–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Van Hare GF, Chiesa NA, Campbell RM, et al. Atrioventricular nodal reentry tachycardia in children: effect of slow pathway ablation on fast pathway conduction. J Cardiovasc Electrophys 2002; 13:203–9.CrossRefGoogle Scholar
  8. 8.
    Dunnigan A, Benditt DG, Benson DW. Modes of onset (“initiating events”) for paroxysmal atrial tachycardia in infants and children. Am J Cardiol 1986; 57:1280–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Friedman RA, Walsh EP, Silka MJ, et al. NASPE Expert Consensus Conference: Radiofrequency catheter ablation in children with and without congenital heart disease. Pacing Clin Electrophysiol 2002; 25:1000–17.PubMedCrossRefGoogle Scholar
  10. 10.
    Frame LH, Page RL, Hoffman BF. Atrial reentry around an anatomic barrier with a partially refractory excitable gap. A canine model of atrial flutter. Circ Res 1986; 58:495–511.PubMedCrossRefGoogle Scholar
  11. 11.
    Zeppenfeld K, Schalij MJ, Bartelings MM, et al. Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus. Circulation 2007; 116:2241–52.PubMedCrossRefGoogle Scholar
  12. 12.
    Cecchin F, Johnsrude CL, Perry JC, et al. Effect of age and surgical technique on symptomatic arrhythmias after the Fontan procedure. Am J Cardiol 1995; 76:386–91.PubMedCrossRefGoogle Scholar
  13. 13.
    Giannico S, Hammad F, Amodeo A, et al. Clinical outcome of 193 extracardiac Fontan patients: the first 15 years. J Am Coll Cardiol 2006; 47:2065–73.PubMedCrossRefGoogle Scholar
  14. 14.
    Villain E. Indications for pacing in patients with congenital heart disease. Pacing Clin Electrophysiol 2008; 31: S17–20.PubMedCrossRefGoogle Scholar
  15. 15.
    Van Hare GF, Lesh MD, Ross BA, et al. Mapping and radiofrequency ablation of intra-atrial reentrant tachycardia after the Senning or Mustard procedure. Am J Cardiol 1996; 77:985–91.PubMedCrossRefGoogle Scholar
  16. 16.
    Garson A, Gillette PC, McVey P, et al. Atrial flutter in the young: a collaborative study of 380 cases. J Am Coll Cardiol 1985; 6:871–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Khairy P, Landzberg MJ, Gatzoulis MA, et al. Value of programmed ventricular stimulation after tetralogy of Fallot repair: a multicenter study. Circulation 2004; 109:1994–2000.PubMedCrossRefGoogle Scholar
  18. 18.
    Therrien J, Siu SC, Harris L, et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation 2001; 103:2489–94.PubMedCrossRefGoogle Scholar
  19. 19.
    Chen P, Xie LJ, Huang GY, et al. Mutations of connexin43 in fetuses with congenital heart malformations. Chin Med J 2005; 118:971–6.PubMedGoogle Scholar
  20. 20.
    Juang JM, Chern YR, Tsai CT, et al. The association of human connexin 40 genetic polymorphisms with atrial fibrillation. Int J Cardiol 2007; 116:107–12.PubMedCrossRefGoogle Scholar
  21. 21.
    Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 Guidelines for the management of adults with congenital heart disease. J Am Coll Cardiol 2008; 52:e1–121.CrossRefGoogle Scholar
  22. 22.
    Piran S, Veldtman G, Siu S, et al. Heart failure and dysfunction in patients with single or systemic right ventricle. Circulation 2002; 105:1189–94.PubMedCrossRefGoogle Scholar
  23. 23.
    Pasquali SK, Marino BS, Kaltman JR, et al. Rhythm and conduction disturbances at midterm follow-up after the Ross procedure in infants, children and young adults. Ann Thorac Surg 2008; 85:2072–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Davlouros PA, Kilner PJ, Hornung TS, et al. Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow tract aneurysms or akinesia and adverse right-to-left ventricular interaction. J Am Coll Cardiol 2002; 40:204–52.CrossRefGoogle Scholar
  25. 25.
    Graham TP, Bernard YD, Mellen BG, et al. Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J Am Coll Cardiol 2000; 36:255–61.PubMedCrossRefGoogle Scholar
  26. 26.
    Hornung TS, Bernard EJ, Jaeggi ET, et al. Myocardial perfusion defects and associated systemic ventricular dysfunction in congenitally corrected transposition of the great arteries. Heart 1998; 80:322–6.PubMedGoogle Scholar
  27. 27.
    Perry JC. Pharmacologic therapy of arrhythmias. In: Wolff GS, Deal BJ, editors. Arrhythmias in the neonate, infant and child. Armonk, NY: Futura Pub. Co., 1998.Google Scholar
  28. 28.
    Ye B, Valdivia CR, Ackerman MA, et al. A common human SCN5A polymorphism modifies expression of an arrhythmia causing mutation. Physiol Genomics 2003; 12:187–93.PubMedGoogle Scholar
  29. 29.
    Perry JC, McQuinn R, Smith RT, et al. Flecainide acetate for resistant arrhythmias in the young: efficacy and pharmacokinetics. J Am Coll Cardiol 1989; 14:185–91.PubMedCrossRefGoogle Scholar
  30. 30.
    Saul JP, Ross B, Schaffer MS, et al. Pharmacokinetics and pharmacodynamics of sotalol in a pediatric population with supraventricular and ventricular tachyarrhythmia. Clin Pharmacol Ther 2001; 69:145–57.PubMedCrossRefGoogle Scholar
  31. 31.
    Epstein AE, Hallstrom AP, Rogers WJ, et al. Mortality following ventricular arrhythmia suppression by encainide, flecainide and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST). JAMA 1993; 270:2451–5.PubMedCrossRefGoogle Scholar
  32. 32.
    Perry JC, Garson A Jr. Flecainide acetate for pediatric tachyarrhythmias: review of world literature on efficacy, safety and dosing. Am Heart J 1992; 124:1614–21.PubMedCrossRefGoogle Scholar
  33. 33.
    Fish FA, Gillette PC, Benson DW. Proarrhythmia, cardiac arrest and sudden death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group. J Am Coll Cardiol 1991; 18:356–65.PubMedCrossRefGoogle Scholar
  34. 34.
    Schaffer MS, Silka MJ, Ross BA, et al. Inadvertent atrioventricular block during radiofrequency catheter ablation. Results of the Pediatric Radiofrequency Catheter Ablation Registry. Circulation 1996; 94:3214–20.PubMedCrossRefGoogle Scholar
  35. 35.
    Al-Ammouri I, Perry JC. Proximity of the coronary arteries to the atrioventricular valve annulus in young patients: implications for ablation procedures. Am J Cardiol 2006; 97:1752–5.PubMedCrossRefGoogle Scholar
  36. 36.
    Van Hare GF, Javitz H, Carmelli D, et al. Prospective assessment after pediatric catheter ablation: demographics, medical profiles, and initial outcomes. J Cardiovasc Electrophys 2004; 15:759–70.CrossRefGoogle Scholar
  37. 37.
    Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm 2008; 5:e1–62.PubMedCrossRefGoogle Scholar
  38. 38.
    Friedman RA, VanZandt H, Collins E, et al. Lead extraction in young patients with and without congenital heart disease. Pacing Clin Electrophysiol 1996; 19:778–83.PubMedCrossRefGoogle Scholar
  39. 39.
    Boramanand NK, Perry JC. Expected prevalence of cardiac rhythm management device need in the adult congenital heart population: evidence of a large and under-treated population. Philadelphia Adult Congenital Heart Symposium, 2007.Google Scholar
  40. 40.
    Berul CI, Van Hare GF, Kertesz NJ, et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Col Cardiol 2008; 51:1685–91.CrossRefGoogle Scholar
  41. 41.
    Jolley M, Stinstra J, Pieper S, et al. A computer modeling tool for comparing novel ICD electrode orientation in children and adults. Heart Rhythm 2008; 5:565–72.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Pediatrics, Cardiology DivisionUniversity of California San Diego/Rady Children’s HospitalSan DiegoUSA

Personalised recommendations